Beruflich Dokumente
Kultur Dokumente
PERIODONTOLOGY 2000
ISSN 0906-6713
105
Geurs et al.
Table 1. Relation between systemic bone mineral density (BMD) and oral bone mineral density
Authors
Population
Major Result
Type of study
158 postmenopausal
women
Age 62.2 7.6 years
Cross-sectional study
45 postmenopausal
women with no or
mild periodontitis
Mean age 57.4 5.8
Cross-sectional study
41 dentate Caucasian
women aged
20 to 78 years
Cross-sectional study
28 healthy women
aged 2378
Cross-sectional study
longitudinal study
von Wowern
et al. (27)
12 women with
osteoporotic fractures
Cross-sectional study
50 normal women
aged 2090
Cross-sectional study
Kribbs (12)
85 osteoporotic women
and 27 normal
women aged 5085
Cross-sectional study
85 osteoporotic women
Cross-sectional study
30 postmenopausal
women
Cross-sectional study
average of 5 years, a positive effect of estrogen replacement therapy on the bone mass of the mandible
and the lumbar spine was observed. Different estrogen regimens resulted in different increases in bone
mass (4).
Streckfus et al. (24) used quantitative measurements of vertical bitewing and hand radiographs in
patients with active periodontitis. The results of the
study showed that postmenopausal women on estrogen therapy had more alveolar bone loss (ABL), more
missing teeth, and reduced alveolar and second metacarpal bone density than premenopausal women.
Alveolar bone densities were also strongly correlated
to second metacarpal densities.
Most studies relate systemic BMD with mandibular mineral density. In a study of both maxilla and
mandible, 41 dentate Caucasian women aged 2078
were evaluated using quantitative intraoral radiography and systemic bone densities determined by dualenergy X-ray absorptiometry (DXA) (23). The density
of maxillary alveolar process bone was significantly
106
107
Geurs et al.
Population
Major result
Type of study
No statistically significant
differences in gingival bleeding,
probing pocket depths, gingival
recession and marginal bone level
Cross-sectional
study
70 postmenopausal Caucasian
women aged 5178
Cross-sectional
study
Cross-sectional
study
Payne (20)
2-year longitudinal
clinical study
In non-smoking osteopenic/
osteoporotic periodontitis patients
with estrogen deficiency had
more bleeding on probing and
clinical attachment levels
2-year prospective
longitudinal study
Cross-sectional
study
28 healthy women
aged 2378
Cross-sectional
study
von Wowern
et al. (27)
Cross-sectional
study
Cross-sectional
study
108
Periodontitis
ABL (mm)
SD
No
No
14 0.18
0.21
No
Yes
11 0.31
0.20
Yes
No
23 0.66
0.62
Yes
Yes
10 1.08
0.46
examinations and quantitative digital intraoral radiography. The intraoral techniques used in this study
have been validated and are over 90% sensitive and
specific in detecting small changes in bone mass and
density (2, 7). Standardized vertical bitewing radiographs were taken at baseline and the 3-year followup visit. The radiographs were digitized and corrected for small angulation errors and contrast. Subtraction radiography was used for the enhancement
of the standardized radiographs. Alveolar bone
height was measured using Periovision software.
Measurements were made on the mesial and distal
aspects of posterior teeth. Alveolar bone height was
defined as the measurement from the cementoenamel junction to the point of bony attachment to
the root of teeth. The patients were recalled and a
similar examination including the radiographic surveys was performed every 3 years.
The amount of ABL along the root surface over the
3-year period was calculated for 58 subjects using
digital subtraction radiography. The subjects were
divided into two groups based on BMD at the hip
measured at baseline. The osteoporosis group was
defined as hipbone mineral density 2.5 SD below
the normal as confirmed by DXA. Subjects with
BMD above this level were considered the nonosteoporosis group. The subjects were also stratified
based on ABL as a measure of the periodontal disease
status at baseline. A subject was considered to have
periodontitis when 3 mm or greater of alveolar bone
height was measured at baseline.
Figure 1 and Table 3 represent the 3-year longitudinal ABL data for the subjects based on periodontal and osteoporosis status. Subjects with
osteoporosis presented with greater progression of
ABL than subjects with no osteoporosis over the 3year period. The subjects with periodontal disease at
baseline exhibited greater amounts of ABL than subjects with periodontal disease. The greatest amount
of ABL was found in the group of subjects with
periodontal disease and osteoporosis. A general linear model was constructed for the outcome variable
change in logarithmic alveolar bone height. Indepen-
dent variables included smoking, age, current hormone replacement therapy, calcium intake, and
ethnicity (P < 0.0008). In the post hoc comparison
of subjects without periodontitis at baseline, the subjects with osteoporosis had greater mean ABL (0.18
0.21 mm versus 0.66 62 mm; P < 0.02). This was
statistically significant. When periodontitis was present at baseline, the difference in mean ABL between
the osteoporosis and non-osteoporosis groups was
even greater. The mean ABL for patients with periodontitis and osteoporosis was 1.08 0.46 mm compared with 0.31 0.20 mm in the non-osteoporosis
group. This was statistically significant (P < 0.01).
These data present a preliminary report of this
ongoing study and indicate a greater propensity to
lose alveolar bone in subjects with osteoporosis especially in subjects with preexisting periodontitis. This
would indicate that osteoporosis or low systemic
BMD should be considered a risk factor for periodontal disease progression. In the future we will report
the data of the ongoing study for the complete study
population and duration.
References
1. Elders PJ, Habets LL, Netelenbos JC, van der Linden LW, van
der Stelt PF. The relation between periodontitis and systemic bone mass in women between 46 and 55 years of age.
J Clin Periodontol 1992: 19: 492496.
2. Hausmann E, Christersson L, Dunford R, Wikesjo U, Phyo J,
Genco RJ. Usefulness of subtraction radiography in the
evaluation of periodontal therapy. J Periodontol 1985: 56:
47.
3. Hildebolt CF, Pilgram TK, Dotson M, Yokoyama-Crothers N,
Muckerman J, Hauser J, Cohen S, Kardaris E, Vannier MW,
Hanes P, Shrout MK, Civitelli R. Attachment loss with post-
109
Geurs et al.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
110
18. Melton LJ, 3rd, Lane AW, Cooper C, Eastell R, OFallon WM,
Riggs BL. Prevalence and incidence of vertebral deformities.
Osteoporos Int 1993: 3: 113119.
19. Mohammad AR, Bauer RL, Yeh CK. Spinal bone density and
tooth loss in a cohort of postmenopausal women. Int
J Prosthodont 1997: 10: 381385.
20. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD.
Longitudinal alveolar bone loss in postmenopausal
osteoporotic/osteopenic women. Osteoporos Int 1999: 10:
3440.
21. Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ,
Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal
women. J Periodontol 1999: 70: 823828.
22. Shrout MK, Hildebolt CF, Potter BJ, Brunsden TK, Pilgram
TK, Dotson M, Yokoyama-Crothers N, Hauser J, Cohen S,
Kardaris E, Civitelli R, Hanes P. Comparison of morphological measurements extracted from digitized dental radiographs with lumbar and femoral bone mineral density
measurements in postmenopausal women. J Periodontol
2000: 71: 335340.
23. Southard KA, Southard TE, Schlechte JA, Meis PA. The relationship between the density of the alveolar processes
and that of post-cranial bone. J Dent Res 2000: 79: 964969.
24. Streckfus CF, Johnson RB, Nick T, Tsao A, Tucci M. Comparison of alveolar bone loss, alveolar bone density and
second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen
therapy. J Gerontol A Biol Sci Med Sci 1997: 52: 343351.
25. Taguchi A, Suei Y, Ohtsuka M, Otani K, Tanimoto K, Hollender LG. Relationship between bone mineral density and
tooth loss in elderly Japanese women. Dentomaxillofacial
Radiol 1999: 28: 219223.
26. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R,
Genco RJ. The relationship between bone mineral density
and periodontitis in postmenopausal women. J Periodontol
2000: 71: 14921498.
27. von Wowern N, Klausen B, Kollerup G. Osteoporosis: a risk
factor in periodontal disease. J Periodontol 1994: 65: 1134
1138.
28. Weyant RJ, Pearlstein ME, Churak AP, Forrest K, Famili P,
Cauley JA. The association between osteopenia and periodontal attachment loss in older women. J Periodontol 1999:
70: 982991
29. WHO. Assessment of fracture risk and its applications to
screening for postmenopausal osteoporosis. WHO Technical Report Series. Geneva: WHO, 1994.